Insights

In the pharmaceutical sector, effective promotion relies on structured plans that combine scientific content, compliant channels, and consistent brand positioning.

Within this framework, gadgets—planned as part of a broader promotional strategy—can serve as a tactical tool to support field interactions, reinforce key messages, strengthen brand recognition, and build a professional connection with healthcare professionals.

However, gadgets are not simply “free gifts,” and they must always comply with strict regulatory requirements: they should be of negligible value, non-cash/non-convertible, and clearly linked to professional practice to prevent undue influence and to safeguard the independence and professional judgment of healthcare professionals.

A key distinction exists between institutional gadgets and promotional gadgets.

While institutional gadgets reinforce a company’s corporate identity without referencing a specific medicine, promotional gadgets are product-linked and therefore subject to stricter requirements including AIFA submission and acceptance before distribution.

Between 2023 and 2025, regulations concerning gadgets became significantly more restrictive, especially regarding the types of objects that can be distributed. Certain objects that were once considered acceptable are now prohibited—particularly gadgets that, by their nature and typical use, could be exposed to the general public.

Today, gadgets remain a useful communication tool, but only when designed to comply with applicable requirements and to support ethical promotion in a clearly professional context.

Regulatory Pharma Net is available to support your company in the development of promotional plans that also include gadgets, ensuring compliance with continuously evolving Italian regulatory requirements.